.png){kind=icon}
返回
Vascular Dysfunction in Preeclampsia
.png){kind=icon}
OA
AI
DOI：10.3390/cells10113055.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Preeclampsia is a life-threatening pregnancy-associated cardiovascular disorder characterized by hypertension and proteinuria at 20 weeks of gestation. Though its exact underlying cause is not precisely defined and likely heterogenous, a plethora of research indicates that in some women with preeclampsia, both maternal and placental vascular dysfunction plays a role in the pathogenesis and can persist into the postpartum period. Potential abnormalities include impaired placentation, incomplete spiral artery remodeling, and endothelial damage, which are further propagated by immune factors, mitochondrial stress, and an imbalance of pro- and antiangiogenic substances. While the field has progressed, current gaps in knowledge include detailed initial molecular mechanisms and effective treatment options. Newfound evidence indicates that vasopressin is an early mediator and biomarker of the disorder, and promising future therapeutic avenues include mitigating mitochondrial dysfunction, excess oxidative stress, and the resulting inflammatory state. In this review, we provide a detailed overview of vascular defects present during preeclampsia and connect well-established notions to newer discoveries at the molecular, cellular, and whole-organism levels.
Keyword:
preeclampsia
pregnancy
gestation
hypertension
vessel
blood pressure
placenta
trophoblast
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
5.2
论文数:
2.1W
被引数:
9.4W
机构
引用论文
.png){kind=icon}
分享收藏分享收藏分享收藏分享收藏Neutropenic Sepsis in the ICU: Outcome Predictors in a Two-Phase Model and Microbiology FindingsOAAI
OAAI分享收藏分享收藏
查看更多内容